SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $38,000 | -55.8% | 1,600 | -38.5% | 0.01% | -56.0% |
| Q2 2019 | $86,000 | -85.9% | 2,600 | -85.4% | 0.02% | -69.5% |
| Q1 2019 | $612,000 | +119.4% | 17,842 | +107.0% | 0.08% | -8.9% |
| Q4 2018 | $279,000 | -22.5% | 8,621 | +19.7% | 0.09% | +32.4% |
| Q3 2018 | $360,000 | +76.5% | 7,201 | +106.2% | 0.07% | +47.8% |
| Q2 2018 | $204,000 | +51.1% | 3,493 | +2.7% | 0.05% | +48.4% |
| Q4 2017 | $135,000 | +2150.0% | 3,400 | +1600.0% | 0.03% | +3000.0% |
| Q1 2017 | $6,000 | -95.2% | 200 | -95.9% | 0.00% | -93.8% |
| Q4 2016 | $124,000 | -65.9% | 4,900 | -72.6% | 0.02% | -68.0% |
| Q2 2016 | $364,000 | -64.6% | 17,891 | -73.5% | 0.05% | -58.0% |
| Q1 2016 | $1,029,000 | +97.9% | 67,491 | +74.4% | 0.12% | +83.1% |
| Q4 2015 | $520,000 | -47.6% | 38,696 | -45.3% | 0.06% | -43.0% |
| Q3 2015 | $992,000 | – | 70,705 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |